Category: Therapeutic Area
Therapeutic Area market research reports by Roots Analysis
-
Digital Biomarkers Market by Type of Product
DIGITAL BIOMARKERS MARKET: OVERVIEW As per Roots Analysis, the global digital biomarkers market is estimated to grow from USD 5.6 billion in the current year to USD 35.8 billion by 2035, at a CAGR of 18.48% during the forecast period, till 2035. The market opportunity for cell and gene therapy suppl ... Read More
-
Bispecific Antibodies Market by Therapeutic Area
BISPECIFIC ANTIBODIES MARKET OVERVIEW As per Roots Analysis, the global bispecific antibodies market is estimated to grow from USD 5.6 billion in the current year to USD 16.8 billion by 2035, at a CAGR of 9.5% during the forecast period, till 2035. The market sizing and opportunity analysis has been ... Read More
-
Oncology Precision Medicine Market by Type of Cancer Targeted
ONCOLOGY PRECISION MEDICINE MARKET: OVERVIEW As per Roots Analysis, the global oncology precision medicine market is estimated to grow from USD 147.9 billion in the current year to USD 364 billion by 2035, at a CAGR of 8.5% during the forecast period, till 2035. The market sizing and opportunity ana ... Read More
-
Oral Solid Dosage Manufacturing Market by Type of Finished Dosage Form
ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET: OVERVIEW As per Roots Analysis, the global oral solid dosage contract manufacturing market is estimated to grow from USD 22.5 billion in the current year to USD 36.52 billion by 2035, at a CAGR of 4.49% during the forecast period, till 2035. The marke ... Read More
-
Plasmid DNA Manufacturing Market by Scale of Operation
PLASMID DNA MANUFACTURING MARKET: OVERVIEW As per Roots Analysis, the global plasmid DNA manufacturing market is estimated to grow from USD 0.1 billion in the current year to USD 0.53 billion by 2035, at a CAGR of 14.85% during the forecast period, till 2035. The market sizing and opportunity analys ... Read More
-
RNA Therapeutics and RNA Vaccines Market by Type of Modality
RNA THERAPEUTICS MARKET AND RNA VACCINES MARKET: OVERVIEW As per Roots Analysis, the global RNA therapeutics market and RNA vaccines market is estimated to grow to USD 940 million by 2035, at a CAGR of 68% during the forecast period, till 2035. The market sizing and opportunity analysis has been seg ... Read More
-
Cancer Biomarkers Market by Type of Biomarker
CANCER BIOMARKERS MARKET: OVERVIEW As per Roots Analysis, the global cancer biomarkers market is estimated to grow from USD 28.6 billion in the current year to USD 46.7 billion by 2035, at a CAGR of 5% during the forecast period, till 2035. The market sizing and opportunity analysis has been segment ... Read More
-
Long-Acting Drug Delivery Technologies and Services Market by Compatible Dosage Form
LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET: OVERVIEW As per Roots Analysis, the global long-acting drug delivery technologies and services market is estimated to grow from USD 1.06 billion in the current year to USD 4.62 billion by 2035, at a CAGR of 13.1% during the forecast period, ... Read More
-
Ultrasound Market by Type of Product Offered (diagnostic ultrasound systems and therapeutic ultrasound systems), Device Portability (trolley / cart-based ultrasound devices and handheld / point-of-care ultrasound devices), Device Display (colored display, and black / white display), Type of Technology (2D technology, 3D / 4D technology, doppler imaging technology, contrast enhanced ultrasound technology, high intensity focused ultrasound technology and extracorporeal shockwave lithotripsy technology), Application Area (radiology / general imaging, cardiology, obstetrics / gynecology, urology, musculoskeletal systems and other application areas), End User (hospitals, diagnostic centers, ambulatory and surgical centers, and research and academic centers), Geographical Regions and Key Players: Industry Trends and Global Forecasts, Till 2035
ULTRASOUND MARKET As per Roots Analysis, the global ultrasound market size is estimated to grow from USD 8.9 billion in the current year to USD 16.0 billion by 2035, at a CAGR of 5.4% during the forecast period, till 2035. The opportunity for ultrasound market has been distributed across the followi ... Read More
-
Targeted Drug Delivery Device Market (2nd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Device (Catheters, Cannulas and Others), Target Organ (Brain, Breast, Eyes and Heart), Type of Therapy Delivered (Cell Therapies, Gene Therapies and Immunotherapies), Route of Administration (Intratumoral, Transendocardial and Others), Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Ophthalmic Disorders and Neurological Disorders) and Key Geographical Regions (North America, Europe and Asia-Pacific), and Leading Players and Sales Forecast
TARGETED DRUG DELIVERY DEVICE MARKET As per Roots Analysis, the global targeted drug delivery device market size is estimated to grow from USD 0.4 billion in 2026 to USD 2.1 billion by 2035, at a CAGR of 19.7% during the forecast period, till 2035. The opportunity for targeted drug delivery device m ... Read More
-
Organs-on-Chips Market by Type of Product (organ based and disease based), Type of Organ (single organ based and multi organ based), Type of Single Organ based Model (liver, lung, brain, heart, intestine, kidney and other organs), Type of Material of Construction (polydimethylsiloxane, other polymer, glass and others), Purpose (research and therapeutic), Application Area (drug discovery / toxicity testing, cancer research, stem cell research, tissue engineering / regenerative medicine and others), End User (pharmaceutical and biotech companies, academic and research players, cosmetic industry players and other end users), Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts, Till 2035
ORGANS-ON-CHIPS MARKET As per Roots Analysis, the global organ on a chip market size is estimated to grow from USD 77 million in the current year to USD 944 million by 2035, at a CAGR of 25. 6% during the forecast period, till 2035. The opportunity for organ on a chip market has been distributed acr ... Read More
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR, and TIL), Target Indications (Acute Lymphoblastic Leukemia, Non-Hodgkin’s Lymphoma, Melanoma, Bladder Cancer, Lung Cancer, Head, and Neck Cancer, Multiple Myeloma, Sarcoma, Chronic Lymphocytic Leukemia, Ovarian Cancer, Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, Europe and Asia Pacific, Latin America, Middle East, and North Africa): Industry Trends and Global Forecasts, Till 2035
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR, and TIL), Target Indications (Acute Lymphoblastic Leukemia, Non-Hodgkin’s Lymphoma, Melanoma, Bladder Cancer, Lung Cancer, Head, and Neck Cancer, Multiple Myeloma, Sarcoma, Chronic Lymphocytic Leukemia, Ovarian Cancer, Esophageal Cancer, Colorect ... Read More
-
Global TCR Therapy Market by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Global TCR Therapy Market by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (No ... Read More
-
Prefilled Syringes Market by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle
Prefilled Syringes Market by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respir ... Read More
-
Deep Learning Market in Drug Discovery and Diagnostics by Therapeutic Area (Oncological Disorders, Infectious Diseases, Neurological Disorders, Immunological Disorders, Endocrine Disorders, Cardiovascular Disorders, Respiratory Disorders, Eye Disorders, Musculoskeletal Disorders, Inflammatory Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Deep Learning Market in Drug Discovery and Diagnostics by Therapeutic Area (Oncological Disorders, Infectious Diseases, Neurological Disorders, Immunological Disorders, Endocrine Disorders, Cardiovascular Disorders, Respiratory Disorders, Eye Disorders, Musculoskeletal Disorders, Inflammatory Disord ... Read More
-
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunological Disorders, Infectious Diseases, Metabolic Disorders, Musculoskeletal Disorders, Neurological Disorders, Oncological Disorders, Rare Diseases, and Other disorders), End-Users (Industry Players and Non-Industry Players) and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Cell and Gene Therapy CRO Market by Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), Type of Genetic Modification (Ex vivo and In vivo), Stage of Development (Discovery, Preclinical, and Clinical), Therapeutic Area (Blood Disorders, Cardiovascular Disorders, Dermatological Disorders, Immunol ... Read More
-
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus Vectors, Herpes Simplex Virus Vectors, Lentivirus Vectors, Non-viral Vectors, Retrovirus Vectors and Other Viral Vectors), Type of Therapy (Gene Augmentation, Gene Editing, Gene Regulation, Oncolytic Immunotherapies and Other Therapies), Type of Gene Delivery Method (Ex Vivo Gene Delivery and In vivo Gene Delivery), Route of Administration (Intramuscular Route, Intratumoral Route, Intravenous Route, Subretinal Route and Other Routes of Administration), Geographical Regions (North America, Europe, Asia-Pacific, Latin America and Rest of the World), Leading Players and Sales Forecast: Industry Trends and Global Forecasts, Till 2035
Gene Therapy Market by Therapeutic Area (Cardiovascular Disorders, Dermatological Disorders, Genetic Disorders, Hematological Disorders, Metabolic Disorders, Muscle Disorders, Oncological Disorders, Ophthalmic Disorders and Other Disorders), Type of Vector (Adeno-associated Virus Vectors, Adenovirus ... Read More
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Cl ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / ... Read More
-
Medical Device CRO Market by Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Metabolic Disorders, Oncological Disorders, Ophthalmological Disorders, Orthopedic Disorders, Pain Disorders, Psychological Disorders, Respiratory Disorders, and Others), Scale of Operation (Clinical / Preclinical), Device Class (Class I, Class II, Class III), Type of Clinical Service Offered (Clinical Trial Management, Data Management, Regulatory Affairs Management, Consulting), Type of Preclinical Service Offered (Biocompatibility Testing, Sterility, Microbiology Testing, Material Characterization, Analytical Services) and Key Geographies (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Medical Device CRO Market by Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Metabolic Disorders, Oncological Disorders, Ophthalmological Disorders, Orthopedic Disorders, Pain Disorders, Psychological Disorders, Respiratory Disorders, and Others), Scale of Operation (Clinical / Pre ... Read More
-
mRNA Synthesis and Manufacturing Market by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
mRNA Synthesis and Manufacturing Market by Type of Product (Drug Substances (APIs) and Drug Products (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders) and Key Geographical Regions (North Amer ... Read More
-
AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-User (Pharmaceutical and Biotechnology Companies, and Other End-Users) and Key Geographical Regions (Asia-Pacific, Europe, Latin America, Middle East and North Africa, and North America): Industry Trends and Global Forecasts, Till 2035
AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-User (Pharmaceutical and Biotechnology Companies, and Other End-U ... Read More
-
DNA Encoded Library Market by Application Area (Hit Generation / Identification, Hit to Lead, Hit Validation / Optimization and Other Application Areas), Therapeutic Area (Oncological Disorders, Immunological Disorders, Neurological Disorders, Respiratory Disorders, Dermatological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Therapeutic Areas), End-users (Pharma / Biopharma Industry, Academic / Research Institute and Other End-users), Type of Payment Model Employed (Upfront Payment and Milestone Payment) and Key Geographical Regions (North America - US, Europe - UK, Germany, Denmark, France, Switzerland and Rest of the Europe, and Asia-Pacific - China): Industry Trends and Global Forecasts, Till 2035
DNA Encoded Library Market by Application Area (Hit Generation / Identification, Hit to Lead, Hit Validation / Optimization and Other Application Areas), Therapeutic Area (Oncological Disorders, Immunological Disorders, Neurological Disorders, Respiratory Disorders, Dermatological Disorders, Cardiov ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Link ... Read More
-
Antibody Discovery Market by Type of Service Offered (Antigen Designing, Hit Generation, Lead Selection, Lead Optimization and Lead Characterization), Antibody Discovery Method (Hybridoma based, Library based, Single Cell based and Transgenic Animal based), Type of Antibody Generated (Monoclonal Antibodies, Bispecific Antibodies and Others), Nature of Antibody Generated (Chimeric, Human, Humanized and Murine), Type of Therapeutic Areas (Cardiovascular Disorders, Immunological Disorders, Infectious Disorders, Neurological Disorders, Oncological Disorders and Others) and Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, Till 2035
Antibody Discovery Market by Type of Service Offered (Antigen Designing, Hit Generation, Lead Selection, Lead Optimization and Lead Characterization), Antibody Discovery Method (Hybridoma based, Library based, Single Cell based and Transgenic Animal based), Type of Antibody Generated (Monoclonal Ant ... Read More
Research Assistance
